Literature DB >> 9445287

The prevalence of obstructive sleep apnea in hypertensives.

C J Worsnop1, M T Naughton, C E Barter, T O Morgan, A I Anderson, R J Pierce.   

Abstract

This study was designed to measure the prevalence of obstructive sleep apnea in untreated and treated hypertensive patients by comparing them with normotensive subjects, taking into account the possible confounding variables body mass index, age, sex, and alcohol consumption. Subjects with no known sleep disorders were recruited, had full polysomnography, and had their blood pressure assessed with a 24-h ambulatory monitor. Subjects with a mean 24-h blood pressure greater than 140/90, and receiving no treatment for, or with no history of, hypertension were classified as untreated hypertensives; those receiving antihypertension medication were classified as treated hypertensives; those with a mean 24-h blood pressure less than 140/90 and no history of hypertension were classified as normotensives. Thirty-eight percent of the 34 untreated and 38% of the 34 treated hypertensives, and 4% of the 25 normotensives had apnea-hypopnea indexes greater than 5. Logistic regression analysis showed that body mass index (p = 0.001), age (p = 0.07), sex (p = 0.07), treated hypertension (p = 0.05), and untreated hypertension (p = 0.06) were associated with the presence of sleep apnea, but that alcohol consumption (p = 0.82) was not. It is concluded that there is a relationship between sleep apnea and hypertension that, although partially explained by the confounding variables body mass index, age, and sex, persists when these are allowed for.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445287     DOI: 10.1164/ajrccm.157.1.9609063

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  49 in total

1.  Contemporary management of refractory hypertension.

Authors:  A B Alper; D A Calhoun
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

2.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

Review 3.  Obstructive sleep apnea and hypertension.

Authors:  David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

4.  Factors associated with undiagnosed obstructive sleep apnoea in hypertensive primary care patients.

Authors:  Anders Broström; Ola Sunnergren; Kristofer Årestedt; Peter Johansson; Martin Ulander; Barbara Riegel; Eva Svanborg
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

Review 5.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

6.  Sense and Sensitivity: Obstructive Sleep Apnea, Morning Blood Pressure, and Occult Hypertension.

Authors:  Richard J Castriotta
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

Review 7.  Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.

Authors:  Karl A Franklin; Eva Lindberg
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 8.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

9.  Lower BMI is a predictor of obstructive sleep apnea in elderly Thai hypertensive patients.

Authors:  Kittisak Sawanyawisuth; Jarin Chindaprasirt; Vichai Senthong; Pattarapong Makarawate; Panita Limpawattana; Aornchuma Domthong; Songkwan Silaruks; Somchit Chumjan
Journal:  Sleep Breath       Date:  2013-02-27       Impact factor: 2.816

Review 10.  Use of continuous positive airway pressure for sleep apnea in the treatment of hypertension.

Authors:  Matthew G Denker; Debbie L Cohen
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.